More on RNAC

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+27.5% Growth)
- Ratings (8.8 Score)

Upcoming Events

- Earnings (11/5/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Cartesian Therapeutics (NQ:RNAC)
Delayed: 9.30 +0.02 (0.22%)
Prev. Close $9.28  
Open$9.16 
52 Wk High$ 
52 Wk Low$ 
Day High$9.48 
Day Low$8.86 
P/E N/A  
EPS$ 
Volume112,137 


Aug 13, 2026 06:34 PM Form SCHEDULE 13G Cartesian Therapeutics, Filed by: BARCLAYS PLC
Aug 7, 2026 07:00 AM Cartesian Therapeutics Announces New Employment Inducement Grants
Aug 6, 2026 07:10 AM Cartesian Therapeutics (RNAC) Tops Q2 EPS by 134c
Aug 6, 2026 07:06 AM Form 10-Q Cartesian Therapeutics, For: Jun 30
Aug 6, 2026 07:04 AM Form 8-K Cartesian Therapeutics, For: Aug 06
Aug 6, 2026 07:01 AM Cartesian Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
Jul 22, 2026 01:11 PM Form SCHEDULE 13G/A Cartesian Therapeutics, Filed by: JPMORGAN CHASE & CO
Jul 2, 2026 07:05 AM Cartesian Therapeutics Announces New Employment Inducement Grants
Jun 17, 2026 04:01 PM Form 8-K Cartesian Therapeutics, For: Jun 12
Jun 12, 2026 04:05 PM Cartesian Therapeutics Announces New Employment Inducement Grant
View All Articles

Entities mentioned with RNAC

View All Entities